1887

Chapter 14 : Prebiotics and Lipid Metabolism

Authors: Nathalie M. Delzenne1, Patrice D. Cani2, Audrey M. Neyrinck3
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Université Catholique de Louvain, School of Pharmacy, MD/FARM/PMNT 7369 UCL, 73 Avenue Mounier, B-1200 Brussels, Belgium; 2: Université Catholique de Louvain, School of Pharmacy, MD/FARM/PMNT 7369 UCL, 73 Avenue Mounier, B-1200 Brussels, Belgium; 3: Université Catholique de Louvain, School of Pharmacy, MD/FARM/PMNT 7369 UCL, 73 Avenue Mounier, B-1200 Brussels, Belgium
Content Type: Monograph
Publication Year: 2008

Category: Clinical Microbiology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Prebiotics and Lipid Metabolism, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815462/9781555814038_Chap14-1.gif /docserver/preview/fulltext/10.1128/9781555815462/9781555814038_Chap14-2.gif

Abstract:

Several oligosaccharides which strictly correspond to the definition of prebiotics exhibit interesting effects on lipid metabolism. The resulting changes in the intestinal microbiota composition or fermentation activity could be implicated in the modulation of fatty acid and cholesterol metabolism. There is not a single biochemical locus through which prebiotics modulate serum, hepatic, and whole-body lipid content in animals. The effects observed depend on the pathophysiological and nutritional conditions. This may help to explain why in humans, where such conditions cannot be so rigorously controlled (namely, in terms of nutrient intake), the reported effects of prebiotics on circulating blood lipids are much more variable. Most of the data described to date have been obtained in animal studies; the relevance of such observations on obesity and cardiovascular disease risk in humans remains a key question, which is also addressed in this chapter. Fundamental research devoted to understanding the biochemical and physiological events (on glucose and lipid homeostasis, on gut hormone secretion, on satiety), as well as clinical research focusing on the target population, is required to achieve progress in the new area of the nutritional management of metabolic syndromes, based on modulation of the gut microbiota and intestinal function by specific food components.

Citation: Delzenne N, Cani P, Neyrinck A. 2008. Prebiotics and Lipid Metabolism, p 183-192. In Versalovic J, Wilson M (ed), Therapeutic Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555815462.ch14

Key Concept Ranking

Fatty Acids
0.53248507
Fatty Acid Synthase
0.49227133
0.53248507
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815462.ch14
1. Adam,, A.,, M. A. Levrat-Verny,, H. W. Lopez,, M. Leuillet,, C. Demigne, and, C. Remesy. 2001. Whole wheat and triticale flours with differing viscosities stimulate cecal fermentations and lower plasma and hepatic lipids in rats. J. Nutr. 131: 1770– 1776.
2. Alles,, M. S.,, N. M. De Roos,, J. C. Bakx,, E. van de Lisdenk,, P. L. Zock, and, G. A. Hautvast. 1999. Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am. J. Clin. Nutr. 69: 64– 69.
3. Andersson, H.,, N. G. Asp, and, A. Bruce. 2001. Health effects of probiotics and prebiotics. A literature review on human studies. Scand. J. Nutr. 45: 48– 75.
4. Backhed,, F.,, H. Ding,, T. Wang,, L. V. Hooper,, G. Y. Koh,, A. Nagy,, C. F. Semenkovich, and, J. I. Gordon. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101: 15718– 15723.
5. Backhed, F.,, J. F. Manchester,, C. F. Semenkovich, and, J. I. Gordon. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA 104: 979– 984.
6. Balcazar-Munoz,, B. R.,, E. Martinez-Abundis, and, M. Gonzalez-Ortiz. 2003. Effect of oral inulin administration on lipid profile and insulin sensitivity in dyslipidemic obese subjects. Rev. Med. Chil. 131: 597– 604.
7. Battilana,, P.,, K. Ornstein,, K. Minehira,, J. M. Schwarz,, K. Ache-son,, P. Schneiter,, J. Burri,, E. Jequier, and, L. Tappy. 2001. Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men. Eur. J. Clin. Nutr. 55: 327– 333.
8. Beylot, M. 2005. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br. J. Nutr. 93(Suppl. 1): S163– S168.
9. Brighenti, F.,, M. C. Casiraghi,, E. Canzi, and, A. Ferrari. 1999. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur. J. Clin. Nutr. 53: 726– 733.
10. Busserolles,, J.,, E. Gueux,, E. Rock,, C. Demigne,, A. Mazur, and, Y. Rayssiguier. 2003. Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J. Nutr. 133: 1903– 1908.
11. Cani,, P. D.,, C. Dewever, and, N. M. Delzenne. 2004. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br. J. Nutr. 92: 521– 526.
12. Cani,, P. D.,, C. Knauf,, M. A. Iglesias,, D. J. Drucker,, N. M. Delzenne, and, R. Burcelin. 2006. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55: 1484– 1490.
13. Cani,, P. D.,, J. Amar,, M. A. Iglesias,, M. Poggi,, C. Knauf,, D. Bastelica,, A. M. Neyrinck,, F. Fava,, K. M. Tuohy,, C. Chabo,, A. Waget,, E. Delmee,, B. Cousin,, T. Sulpice,, B. Chamontin,, J. Ferrieres,, J. F. Tanti,, G. R. Gibson,, L. Casteilla,, N. M. Delzenne,, M. C. Alessi, and, R. Burcelin. 2007a. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761– 1772.
14. Cani,, P. D.,, S. Hoste,, Y. Guiot, and, N. M. Delzenne. 2007b. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br. J. Nutr. 98: 32– 37.
15. Cani,, P. D.,, A. M. Neyrinck,, F. Fava,, C. Knauf,, R. G. Burcelin,, K. M. Tuohy,, F. K. Gibbons, and, N. M. Delzenne. 2007c. Selective increases of bifidobacteria in gut microflora improve high-fat diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374– 2380.
16. Causey,, J. L.,, J. M. Feirtag,, D. D. Gallaher,, B. C. Tungland, and, J. L. Slavin. 2000. Effects of dietary inulin on serum lipids, blood glucose, and the gastrointestinal environment in hypercholesterolemic men. Nutr. Res. 20: 191– 201.
17. Cheng,, H. H., and, M. H. Lai. 2000. Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats. J. Nutr. 130: 1991– 1995.
18. Daubioul,, C.,, N. Rousseau,, R. Demeure,, B. Gallez,, H. Taper,, B. Declerck, and, N. Delzenne. 2002. Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J. Nutr. 132: 967– 973.
19. Daubioul,, C. A.,, Y. Horsmans,, P. Lambert,, E. Danse, and, N. M. Delzenne. 2005. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur. J. Clin. Nutr. 59: 723– 726.
20. Daubioul,, C. A.,, H. S. Taper,, L. D. De Wispelaere, and, N. M. Delzenne. 2000. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J. Nutr. 130: 1314– 1319.
21. Davidson,, M. H.,, K. C. Maki,, C. Synecki,, S. A. Torri, and, K. B. Drennan. 1998. Effects of dietary inulin on serum lipids in men and women with hypercholesterolemia. Nutr. Res. 18: 503– 517.
22. Delmée,, E.,, P. D. Cani,, G. Gual,, C. Knauf,, R. Burcelin,, N. Maton, and, N. M. Delzenne. 2006. Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci. 79: 1007– 1013.
23. Delzenne,, N. M., and, N. Kok. 1998. Effect of non-digestible fermentable carbohydrates on hepatic fatty acid metabolism. Biochem. Soc. Trans. 26: 228– 230.
24. Delzenne,, N. M.,, and C. Williams. 1999. Actions of non-digestible carbohydrates on blood lipids in humans and animals, p. 213–232. In G. Gibson, and, M. Roberfroid (ed.), Colonic Microbiota, Nutrition and Health. Kluwer Academic Publisher, Dordrecht, The Netherlands.
25. Delzenne, N. M., and, N. Kok. 2001. Effects of fructans-type prebiotics on lipid metabolism. Am. J. Clin. Nutr. 73: 456S– 458S.
26. Delzenne,, N. M., and, C. M. Williams. 2002. Prebiotics and lipid metabolism. Curr. Opin. Lipidol. 13: 61– 67.
27. Delzenne,, N. M.,, C. Daubioul,, A. Neyrinck,, M. Lasa, and, H. S. Taper. 2002. Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br. J. Nutr. 87(Suppl. 2): S255– S259.
28. Delzenne, N., and, P. D. Cani. 2005. A place for dietary fibres in the management of metabolic syndrome. Curr. Opin. Clin. Nutr. Metab. Care 8: 638– 640.
29. Delzenne,, N. M.,, P. D. Cani, and, A. Neyrinck. 2007. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J. Nutr. 137(11 Suppl.): 2547S– 2551S.
30. Demigne,, C.,, C. Morand,, M. A. Levrat,, C. Besson,, C. Moundras, and, C. Remesy. 1995. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br. J. Nutr. 74: 209– 219.
31. Demigne, C.,, C. Remesy, and, C. Morand. 1999. Short chain fatty acids, p. 55–63. In G. Gibson and, M. Roberfroid (ed.), Colonic Microbiota, Nutrition and Health. Kluwer Academic Publisher, Dordrecht, The Netherlands.
32. Diez, M.,, J. L. Hornick,, P. Baldwin, and, L. Istasse. 1997. Influence of a blend of fructo-oligosaccharides and sugar beet fiber on nutrient digestibility and plasma metabolite concentrations in healthy beagles. Am. J. Vet. Res. 58: 1238– 1242.
33. Fabian, E., and, I. Elmadfa. 2006. Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann. Nutr. Metab. 50: 387– 393.
34. Fava, F.,, J. A. Lovegrove,, R. Gitau,, K. G. Jackson, and, K. M. Tuohy. 2006. The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. Curr. Med. Chem. 13: 3005– 3021.
35. Ferchaud-Roucher, V.,, E. Pouteau,, H. Piloquet,, Y. Zair, and, M. Krempf. 2005. Colonic fermentation from lactulose inhibits lipolysis in overweight subjects. Am. J. Physiol. Endocrinol. Metab. 289:E716–E720.
36. Ferre, P., and, F. Foufelle. 2007. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm. Res. 68: 72– 82.
37. Fiordaliso,, M.,, N. Kok,, J. P. Desager,, F. Goethals,, D. Deboyser,, M. Roberfroid, and, N. Delzenne. 1995. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 30: 163– 167.
38. Forcheron, F., and, M. Beylot. 2007. Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism 56: 1093– 1098.
39. Fukushima,, M.,, T. Ohashi,, M. Kojima,, K. Ohba,, H. Shimizu,, K. Sonoyama, and, M. Nakano. 2001. Low density lipoprotein receptor mRNA in rat liver is affected by resistant starch of beans. Lipids 36: 129– 134.
40. Gallaher,, D. D.,, C. M. Gallaher,, G. J. Mahrt,, T. P. Carr,, C. H. Hollingshead,, R. Hesslink, Jr., and, J. Wise. 2002. A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in over-weight normocholesterolemic humans. J. Am. Coll. Nutr. 21: 428– 433.
41. Giacco,, R.,, G. Clemente,, D. Luongo,, G. Lasorella,, I. Fiume,, F. Brouns,, F. Bornet,, L. Patti,, P. Cipriano,, A. A. Rivellese, and, G. Riccardi. 2004. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin. Nutr. 23: 331– 340.
42. Griffiths,, E. A.,, L. C. Duffy,, F. L. Schanbacher,, H. Qiao,, D. Dryja,, A. Leavens,, J. Rossman,, G. Rich,, D. Dirienzo, and, P. L. Ogra. 2004. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig. Dis. Sci. 49: 579– 589.
43. Havenaar, R.,, S. Bonnin-Marol,, W. Van Dokkum,, S. Petitet, and, G. Schaafsma. 1999. Inulin: fermentation and microbial ecology in the intestinal tract. Food Rev. Int. 15: 109– 120.
44. Hidaka, H.,, Y. Tashiro, and, T. Eida. 1991. Proliferation of bifidobacteria by oligosaccharides and their useful effect on human health. Bifidobacteria Microflora 10: 65– 79.
45. Higgins,, J. A.,, M. A. Brown, and, L. H. Storlien. 2006. Consumption of resistant starch decreases postprandial lipogenesis in white adipose tissue of the rat. Nutr. J. 5:25.
46. Hokfelt,, T.,, C. Broberger,, M. Diez,, Z. Q. Xu,, T. Shi,, J. Kopp,, X. Zhang,, K. Holmberg,, M. Landry, and, J. Koistinaho. 1999. Galanin and NPY, two peptides with multiple putative roles in the nervous system. Horm. Metab. Res. 31: 330– 334.
47. Jackson,, K. G.,, G. R. J. Taylor,, A. M. Clohessy, and, C. M. Williams. 1999. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br. J. Nutr. 82: 23– 30.
48. Jenkins,, D. J., and, C. W. Kendall. 2000. Resistant starches. Curr. Opin. Gastroenterol. 16: 178– 183.
49. Jenkins,, D. J.,, V. Vuksan,, C. W. Kendall,, P. Wursch,, R. Jeffcoat,, S. Waring,, C. C. Mehling,, E. Vidgen,, L. S. Augustin, and, E. Wong. 1998. Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J. Am. Coll. Nutr. 17: 609– 616.
50. Jenkins,, D. J.,, V. Vuksan,, A. V. Rao,, E. Vidgen,, C. W. Kendall,, N. Tariq,, P. Wursch,, B. Koellreutter,, N. Shiwnarain, and, R. Jeffcoat. 1999. Colonic bacterial activity and serum lipid risk factors for cardiovascular disease. Metabolism 48: 264– 268.
51. Kang,, S. A.,, K. Hong,, K. H. Jang,, Y. Y. Kim,, R. Choue, and, Y. Lim. 2006. Altered mRNA expression of hepatic lipogenic enzyme and PPARalpha in rats fed dietary levan from Zymomonas mobilis. J. Nutr. Biochem. 17: 419– 426.
52. Kok, N.,, M. Roberfroid, and, N. Delzenne. 1996. Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism. Metabolism 45: 1547– 1550.
53. Lerer-Metzger,, M.,, S. W. Rizkalla,, J. Luo,, M. Champ,, M. Kabir,, F. Bruzzo,, F. Bornet, and, G. Slama. 1996. Effects of long-term low-glycaemic index starchy food on plasma glucose and lipid concentrations and adipose tissue cellularity in normal and diabetic rats. Br. J. Nutr. 75: 723– 732.
54. Letexier, D.,, F. Diraison, and, M. Beylot. 2003. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am. J. Clin. Nutr. 77: 559– 564.
55. Levrat,, M. A.,, M. L. Favier,, C. Moundras,, C. Remesy,, C. Demigne, and, C. Morand. 1994. Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J. Nutr. 124: 531– 538.
56. Levrat,, M. A.,, C. Remesy, and, C. Demigne. 1991. High propionic acid fermentations and mineral accumulation in the cecum of rats adapted to different levels of inulin. J. Nutr. 121: 1730– 1737.
57. Ley,, R. E.,, F. Backhed,, P. Turnbaugh,, C. A. Lozupone,, R. D. Knight, and, J. I. Gordon. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102: 11070– 11075.
58. Ley,, R. E.,, P. J. Turnbaugh,, S. Klein, and, J. I. Gordon. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022– 1023.
59. Lopez,, H. W.,, M. A. Levrat,, C. Guy,, A. Messager,, C. Demigne, and, C. Remesy. 1999. Effects of soluble corn bran arabinoxylans on cecal digestion, lipid metabolism, and mineral balance (Ca, Mg) in rats. J. Nutr. Biochem. 10: 500– 509.
60. Lopez,, H. W.,, M. A. Levrat-Verny,, C. Coudray,, C. Besson,, V. Krespine,, A. Messager,, C. Demigne, and, C. Remesy. 2001. Class 2 resistant starches lower plasma and liver lipids and improve mineral retention in rats. J. Nutr. 131: 1283– 1289.
61. Lovegrove,, J. A.,, A. Clohessy,, H. Milon, and, C. M. Williams. 2000. Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am. J. Clin. Nutr. 72: 49– 55.
62. Luo,, J.,, S. W. Rizkalla,, C. Alamowitch,, A. Boussairi,, A. Blayo,, J. L. Barry,, A. Laffitte,, F. Guyon,, F. R. Bornet, and, G. Slama. 1996. Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am. J. Clin. Nutr. 63: 939– 945.
63. Luo,, J.,, M. Van Yperselle,, S. W. Rizkalla,, F. Rossi,, F. R. Bornet, and, G. Slama. 2000. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J. Nutr. 130: 1572– 1577.
64. McNaught,, C. E., and, J. MacFie. 2001. Probiotics in clinical practice: a critical review of the evidence. Nurs. Res. 21: 343– 353.
65. Morrison,, D. J.,, W. G. Mackay,, C. A. Edwards,, T. Preston,, B. Dodson, and, L. T. Weaver. 2006. Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br. J. Nutr. 96: 570– 577.
66. Mortensen, A.,, M. Poulsen, and, H. Frandsen. 2002. Effect of a long-chained fructan Raftiline HP on blood lipids and spontaneous atherosclerosis in low density receptor knockout mice. Nutr. Res. 22: 473– 480.
67. Pedersen, A.,, B. Sandstrom, and, J. M. M. VanAmelsvoort. 1997. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br. J. Nutr. 78: 215– 222.
68. Pomeroy, S.,, R. Tupper,, M. Cehun-Aders, and, P. Nestel. 2001. Oat beta-glucan lowers total and LDL-cholesterol. Aust. J. Nutr. Diet. 58: 51– 55.
69. Queenan,, K. M.,, M. L. Stewart,, K. N. Smith,, W. Thomas,, R. G. Fulcher, and, J. L. Slavin. 2007. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr. J. 6:6.
70. Rault-Nania,, M. H.,, E. Gueux,, C. Demougeot,, C. Demigne,, E. Rock, and, A. Mazur. 2006. Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice. Br. J. Nutr. 96: 840– 844.
71. Rawls,, J. F.,, M. A. Mahowald,, R. E. Ley, and, J. I. Gordon. 2006. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127: 423– 433.
72. Roberfroid,, M. B., and, N. M. Delzenne. 1998. Dietary fructans. Annu. Rev. Nutr. 18: 117– 143.
73. Sakakibara, S.,, T. Yamauchi,, Y. Oshima,, Y. Tsukamoto, and, T. Kadowaki. 2006. Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice. Biochem. Biophys. Res. Commun. 344: 597– 604.
74. Schaafsma, G.,, W. J. Meuling,, W. Van Dokkum, and, C. Bouley. 1998. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur. J. Clin. Nutr. 52: 436– 440.
75. Scheppach, W.,, H. Luehrs, and, T. Menzel. 2001. Beneficial health effects of low-digestible carbohydrate consumption. Br. J. Nutr. 85(Suppl. 1): S23– S30.
76. Slavin,, J. L. 2005. Dietary fiber and body weight. Nutrition 21: 411– 418.
77. St Onge,, M. P.,, E. R. Farnworth, and, P. J. Jones. 2000. Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. Am. J. Clin. Nutr. 71: 674– 681.
78. Sugatani,, J.,, T. Wada,, M. Osabe,, K. Yamakawa,, K. Yoshinari, and, M. Miwa. 2006. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression. Drug. Metab. Dispos. 34: 1677– 1687.
79. Takase, S.,, T. Goda, and, M. Watanabe. 1994. Monostearoylglycerol-starch complex: its digestibility and effects on glycemic and lipogenic responses. J. Nutr. Sci. Vitaminol. (Tokyo) 40: 23– 36.
80. Taylor,, G. R. J., and, C. M. Williams. 1998. Effects of probiotics and prebiotics on blood lipids. Br. J. Nutr. 80:S225–S230.
81. Tokunaga, T.,, T. Oku, and, N. Hosoya. 1986. Influence of chronic intake of new sweetener fructooligosaccharide (Neosugar) on growth and gastrointestinal function of the rat. J. Nutr. Sci. Vitaminol. (Tokyo) 32: 111– 121.
82. Trautwein,, E. A.,, K. Forgbert,, D. Rieckhoff, and, H. F. Erbersdobler. 1999. Impact of beta-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters. Biochim. Biophys. Acta 1437: 1– 12.
83. Trautwein,, E. A.,, D. Rieckhoff, and, H. F. Erbersdobler. 1998. Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J. Nutr. 128: 1937– 1943.
84. Turnbaugh,, P. J.,, R. E. Ley,, M. A. Mahowald,, V. Magrini,, E. R. Mardis, and, J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027– 1031.
85. Usman,, K. E., and, A. Hosono. 2000. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J. Dairy Sci. 83: 1705– 1711.
86. Vogt,, J. A.,, K. B. Ishii-Schrade,, P. B. Pencharz,, P. J. Jones, and, T. M. Wolever. 2006. L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. J. Nutr. 136: 2160– 2166.
87. Wang,, Z.,, G. Xiao,, Y. Yao,, S. Guo,, K. Lu, and, Z. Sheng. 2006. The role of bifidobacteria in gut barrier function after thermal injury in rats. J. Trauma 61: 650– 657.
88. Wang,, Z. T.,, Y. M. Yao,, G. X. Xiao, and, Z. Y. Sheng. 2004. Risk factors of development of gut-derived bacterial trans-location in thermally injured rats. World J. Gastroenterol. 10: 1619– 1624.
89. Whelan, K.,, G. R. Gibson,, P. A. Judd, and, M. A. Taylor. 2001. The role of probiotics and prebiotics in the management of diarrhoea associated with enteral tube feeding. J. Hum. Nutr. Diet. 14: 423– 433.
90. Williams,, C. M., and, K. G. Jackson. 2002. Inulin and oligofructose: effects on lipid metabolism from human studies. Br. J. Nutr. 87:S261–S264.
91. Xiong,, Y.,, N. Miyamoto,, K. Shibata,, M. A. Valasek,, T. Motoike,, R. M. Kedzierski, and, M. Yanagisawa. 2004. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. USA 101: 1045– 1050.
92. Yamamoto,, Y.,, Y. Takahashi,, M. Kawano,, M. Iizuka,, T. Matsumoto,, S. Saeki, and, H. Yamaguchi. 1999. In vitro digestibility and fermentability of levan and its hypocholesterolemic effects in rats. J. Nutr. Biochem. 10: 13– 18.
93. Yamashita, K.,, M. Itakura, and, K. Kawai. 1984. Effects of fructo-oligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr. Res. 4: 961– 966.

Tables

Prebiotics and Lipid Metabolism
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815462.ch14-1,webId=/content/author/10.1128/9781555815462.ch14-1,properties={foaf_givenname=Nathalie M., foaf_name=Nathalie M. Delzenne, foaf_surname=Delzenne, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815462.ch14-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815462.ch14-2,webId=/content/author/10.1128/9781555815462.ch14-2,properties={foaf_givenname=Patrice D., foaf_name=Patrice D. Cani, foaf_surname=Cani, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815462.ch14-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815462.ch14-3,webId=/content/author/10.1128/9781555815462.ch14-3,properties={foaf_givenname=Audrey M., foaf_name=Audrey M. Neyrinck, foaf_surname=Neyrinck, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815462.ch14-aff3]]}]]
Citation: Delzenne N, Cani P, Neyrinck A. 2008. Prebiotics and Lipid Metabolism, p 183-192. In Versalovic J, Wilson M (ed), Therapeutic Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555815462.ch14
/content/10.1128/9781555815462.ch14.ch14table01
Table 1
Effects of inulin-type fructans on lipid metabolism in humans
Generic image for table
Table 1

Effects of inulin-type fructans on lipid metabolism in humans

Citation: Delzenne N, Cani P, Neyrinck A. 2008. Prebiotics and Lipid Metabolism, p 183-192. In Versalovic J, Wilson M (ed), Therapeutic Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555815462.ch14

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error